chitosan has been researched along with Communicable Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Acosta, J; Altamirano, C; Bertinat, R; Fernández, K; González-Chavarría, I; Kappes, T; Muñoz-Flores, C; Roa, FJ; Sánchez, O; Sandoval, F; Toledo, JR; Valenzuela, A | 1 |
González-Fernández, Á; Reljic, R | 1 |
Cong, H; Hu, H; Meng, Q; Sun, Y; Xu, FJ | 1 |
Halbus, AF; Horozov, TS; Paunov, VN | 1 |
Friedman, AJ; Landriscina, A; Rosen, J | 1 |
3 review(s) available for chitosan and Communicable Diseases
Article | Year |
---|---|
An overview of chitosan and its application in infectious diseases.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bandages; Biocompatible Materials; Chitosan; Communicable Diseases; COVID-19; COVID-19 Drug Treatment; Humans; Wound Healing | 2021 |
Colloid particle formulations for antimicrobial applications.
Topics: Anti-Infective Agents; Antibodies, Bacterial; Biocompatible Materials; Chitosan; Colloids; Communicable Diseases; Copper; Dextrans; Drug Carriers; Drug Compounding; Gold; Green Chemistry Technology; Humans; Lignin; Metal Nanoparticles; Oxides; Silver | 2017 |
Biodegradable chitosan nanoparticles in drug delivery for infectious disease.
Topics: Anti-Infective Agents; Biocompatible Materials; Chitosan; Communicable Diseases; Drug Carriers; Humans; Nanoparticles | 2015 |
2 other study(ies) available for chitosan and Communicable Diseases
Article | Year |
---|---|
Chitosan Microparticles Enhance the Intestinal Release and Immune Response of an Immune Stimulant Peptide in
Topics: Animals; Anti-Bacterial Agents; Chitosan; Communicable Diseases; Fish Diseases; Immunity, Innate; Interleukin-8; Intestines; Oncorhynchus mykiss; Peptides | 2023 |
Editorial: Nanoparticle Vaccines Against Infectious Diseases.
Topics: Chitosan; Communicable Disease Control; Communicable Diseases; Humans; Nanoparticles; Oligodeoxyribonucleotides; Vaccination; Vaccines | 2019 |